BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.190
+0.010 (0.85%)
At close: Apr 15, 2026, 4:00 PM EDT
1.170
-0.020 (-1.68%)
Pre-market: Apr 16, 2026, 4:08 AM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $13.02 million as of April 16, 2026. Its market cap has decreased by -0.65% in one year.
Market Cap
13.02M
Enterprise Value
11.05M
1-Year Change
-0.65%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $13.02M, a decrease of -55.22%. That is a compound annual growth rate of -8.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 12.91M | -2.69% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IN8bio | 13.79M |
| Intensity Therapeutics | 13.46M |
| Hoth Therapeutics | 13.33M |
| Moleculin Biotech | 13.02M |
| Cellectar Biosciences | 12.89M |
| Kairos Pharma | 12.85M |
| Cyclerion Therapeutics | 12.81M |
| Imunon | 12.36M |